Price T Rowe Associates Inc. MD Cuts Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
Price T Rowe Associates Inc. MD cut its stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 94.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 126,806 shares of the biotechnology company’s stock after selling 2,125,943 shares during the quarter. […]
Price T Rowe Associates Inc. MD cut its stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 94.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 126,806 shares of the biotechnology company’s stock after selling 2,125,943 shares during the quarter. […]
